The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Efferocytosis induces macrophage proliferation to help resolve tissue injury
Open accessAbstract
Apoptotic cell clearance by macrophages (efferocytosis) promotes resolution signaling pathways, which can be triggered by molecules derived from the phagolysosomal degradation of apoptotic cells. We show here that nucleotides derived from the hydrolysis of apoptotic cell DNA by phagolysosomal DNase2a activate a DNA-PKcs-mTORC2/Rictor pathway that increases Myc to promote non-inflammatory macrophage proliferation. Efferocytosis-induced proliferation expands the pool of resolving macrophages in vitro and in mice, including zymosan-induced peritonitis, dexamethasone-induced thymocyte apoptosis, and atherosclerosis regression. In the dexamethasone-thymus model, hematopoietic Rictor deletion blocked efferocytosing macrophage proliferation, apoptotic cell clearance, and tissue resolution. In atherosclerosis regression, silencing macrophage Rictor or DNase2a blocked efferocyte proliferation, apoptotic cell clearance, and plaque stabilization. In view of previous work showing that other types of apoptotic cell cargo can promote resolution in individual efferocytosing macrophages, the findings here suggest that signaling-triggered apoptotic cell-derived nucleotides can amplify this benefit by increasing the number of these macrophages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This expands the pool of reparative macrophages, enhancing their capacity for continual apoptotic cell clearance and tissue resolution, and may underlie the sustained reparative capacity exhibited by MerTK+ macrophages (46).”
From Macrophage duality in liver diseases: heterogeneity, plasticity, and the quest for precision therapeutics (2026) · cites this paper as [46]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mechanistically, this approach can harness pathways such as EIMP, which stabilizes a reparative phenotype via the DNase2a-DNA-PKcs-mTORC2-Myc axis (46).”
From Macrophage duality in liver diseases: heterogeneity, plasticity, and the quest for precision therapeutics (2026) · cites this paper as [46]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This aligns with previous research suggesting a role for lipid metabolism in TAM-mediated efferocytosis.”
From Macrophage efferocytosis mediated by the TP63-RAC2 pathway promotes immunosuppressive remodeling in esophageal cancer (2026) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Complementing this rapid functional rewiring, efferocytosis itself can trigger macrophage proliferation through a defined DNase2a–DNA-PKcs–mTORC2–Myc pathway — a process termed efferocytosis-induced macrophage proliferation (EIMP).”
From Macrophage duality in liver diseases: heterogeneity, plasticity, and the quest for precision therapeutics (2026) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Martinez, J., Malireddi, R. K. S., Lu, Q., Cunha, L. D., Pelletier, S., Gingras, S., Orchard, R., Guan, J.-L., Tan, H., Peng, J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3192 · Cited by 758
RetractedMacrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Dyk, D. E. V., Pitts, W. J., Earl, R. A., Hobbs, F. W., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18623 · Cited by 3,016
Hashimoto, D., Chow, A., Noizat, C., Teo, P., Beasley, M. B., Leboeuf, M., Becker, C. D., See, P., Price, J., Lucas, D., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.004 · Cited by 2,311
Immunosuppressive effects of apoptotic cells
Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., & Girkontaite, I. (1997) · Nature · doi:10.1038/37022 · Cited by 1,787
Immunometabolism governs dendritic cell and macrophage function
O'Neill, L. A. J., & Pearce, E. J. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20151570 · Cited by 1,779
Jenkins, S. J., Rückerl, D., Cook, P. C., Jackson-Jones, L. H., Finkelman, F. D., van Rooijen, N., MacDonald, A. S., & Allen, J. E. (2011) · Science · doi:10.1126/science.1204351 · Cited by 1,404
Efferocytosis in health and disease
Doran, A. C., Yurdagul, A., & Tabas, I. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0240-6 · Cited by 1,066
Self-citationLocal proliferation dominates lesional macrophage accumulation in atherosclerosis
Robbins, C. S., Hilgendorf, I., Weber, G. F., Theurl, I., Iwamoto, Y., Figueiredo, J.-L., Gorbatov, R., Sukhova, G. K., Gerhardt, L. M. S., Smyth, D., et al. (2013) · Nature Medicine · doi:10.1038/nm.3258 · Cited by 1,041
Cited by
Sorted by citations
Items 201–300 of 363
Shi, L., Qian, Q., Xie, J., Yang, T., Zhao, X., Meng, X., Dai, J., & Jin, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1649790 · Cited by 5
Liu, Y., Zhu, J., Zhou, S., Hou, Y., Yan, Z., Ao, X., Wang, P., Zhou, L., Chen, H., Liang, X., et al. (2024) · MedComm · doi:10.1002/mco2.690 · Cited by 5
Immunomodulatory effect of efferocytosis at the maternal–fetal interface
Tao, H., Ma, R., Cui, J., Yang, Z., He, W., Li, Y., & Zhao, Y. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02055-9 · Cited by 5
Luo, B., Sun, H., Wang, Y., Zhang, J.-C., Bai, X., Ji, X.-Z., Xie, R.-Z., Liu, Q., & Ru-jun, C. (2024) · Medicine · doi:10.1097/md.0000000000036304 · Cited by 5
Macrophage efferocytosis is controlled by epigenetic modifications mediated by RBPJPreprint
Sadaf, S., Zhang, X., Lei, L., Shen, J., Jamal, I., Modugu, G., & Dutta, P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.10.681723 · Cited by 8
Bao, X., Dun, Y., Hu, H., Tang, Y., Liu, F., Zhou, J., & Shen, J. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114968 · Cited by 4
Maueröder, C., Gillis, C. M., & Ravichandran, K. S. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-92785-0_2 · Cited by 5
Functions of Macrophages in Periodontal Disease Progression and Gingival Tissue Homeostasis
Yamaguchi, T. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-032-03176-1_32 · Cited by 4
The signaling and regulatory functions of dying cells and cell corpses
Zhang, G., Liu, J. Q., Li, W., Wang, B., Feng, H., Cui, T., Pan, T., Chen, D.-P., & Xiong, Y. (2026) · Communications Biology · doi:10.1038/s42003-026-10428-0 · Cited by 4
Cheng, M., Yu, X., Qi, S., Yang, K., Lu, M., Cao, F., & Yu, G. (2024) · Angewandte Chemie · doi:10.1002/ange.202407398 · Cited by 4
Impaired CAMK4 Activity Limits Atherosclerosis and Reprograms Myelopoiesis
Gonzalez, A. L., Youwakim, C. M., Leake, B. F., Fuller, K., Rahman, S. M. J., Dungan, M. M., Gu, K., Bonin, J. L., Cavnar, A. B., Michell, D. L., et al. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.322530 · Cited by 4
Self-citationLi, B., Feng, L., Gao, Z., Zhou, X., Zheng, D., Zhang, X., Sun, M., Xu, Y., Li, W., Wang, Y., et al. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.08.011 · Cited by 5
Lactate helps in tissue repair by promoting efferocytosis-induced macrophage proliferation
(2023) · Nature Metabolism · doi:10.1038/s42255-023-00920-w · Cited by 4
Zhao, Y., Xu, H., Liu, Q., Yuan, Y., Li, R., Li, D., Zhang, Y., Ran, J., Yan, X., & Su, J. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114318 · Cited by 4
EPOR activation attenuates colitis via enhancing LC3B ‐dependent apoptotic cell clearance
Liu, X., Zhang, L., Zhang, Y., Duan, T., Ding, Y., Pan, C., Xu, L., Cheng, Q., Ni, M., & Zhang, Z. (2023) · Immunology · doi:10.1111/imm.13660 · Cited by 4
Qin, D., Zhang, Y., Liu, F., Xu, X., Jiang, H., Su, Z., & Xia, L. (2024) · Acta Physiologica · doi:10.1111/apha.14088 · Cited by 5
Chen, J., Zheng, C., Zhang, F., Sun, S., Liu, G., & Huang, G. C. (2025) · Discover Oncology · doi:10.1007/s12672-025-02961-x · Cited by 3
Esaxerenone inhibits renal macrophage proliferation through MR/TGF-β1 pathway in db/db mice
Yang, F., Liu, Z., Li, Y., Lv, R., Zhao, Y., FanYang, Shimosawa, T., Tan, J., Xu, Q., & Qiang, P. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.124008 · Cited by 3
Wang, Q., Hu, X., Xiao, Z., Ye, K., Li, J., Tan, J., Rao, N., Zhang, D., Sun, G., Cai, M., et al. (2025) · Regenerative Biomaterials · doi:10.1093/rb/rbaf118 · Cited by 3
Death as rebirth: how efferocytosis drives tissue repair and disease treatment
Duan, X., Han, S., Bian, Y., Yuan, Y., Shen, J., Dai, Y., Mi, J., & Wang, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1712547 · Cited by 3
Macrophage efferocytosis in cardiovascular disease: mechanisms and therapeutic implications
Gupta, N., Liu, Y., & Cai, B. (2026) · ImmunoHorizons · doi:10.1093/immhor/vlag002 · Cited by 3
Meng, C., Tao, S., Li, Y., Li, J., Huang, X., Xia, X., & Liu, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1782933 · Cited by 3
Liu, J., Wen, Z., Tang, S., Wu, J., Bi, X., Yang, Y., & Huang, C. (2026) · Toxins · doi:10.3390/toxins18040155 · Cited by 3
In vitro Assessment of Efferocytic Capacity of Human Macrophages Using Flow Cytometry
Salina, A. C. G., Fortes-Rocha, M., & Cunha, L. D. (2023) · BIO-PROTOCOL · doi:10.21769/bioprotoc.4903 · Cited by 3
FFAR4 Deficiency Increases Necrotic Cores in Advanced Lesions of ApoE −/− Mice—Brief Report
Stuttgen, G. M., Bobek, J. M., Penoske, R. M., Wadding-Lee, C., Lam, M., Hader, S. N., Owens, A. P., & Sahoo, D. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.322371 · Cited by 3
Advancements in macrophage research for cardiovascular disease
Cao, M., Sun, Y., Zhang, X., Zou, J., Shi, M., Li, L., & Jiang, H. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1647865 · Cited by 3
A bibliometric analysis of efferocytosis in cardiovascular diseases from 2001 to 2022
Hu, L., Lv, Z., Gu, Y., Zheng, T., Kong, Y., & Mao, W. (2023) · Medicine · doi:10.1097/md.0000000000034366 · Cited by 3
Zhou, X., He, J., Song, H., Zhao, W., Li, R., Han, W., & Li, Q. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.03.003 · Cited by 3
Cancer cell phagocytosis induces an anti-inflammatory gene regulatory program in macrophagesPreprint
Zhang, C. R., Xiong, L., Gu, M., Yeh, C. Y., Jerby‐Arnon, L., Kundaje, A. B., Greenleaf, W. J., & Bassik, M. C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.18.670953 · Cited by 3
Zhang, Z., Mo, Y., Xu, S., Jiang, L., Peng, Y., ZhuGe, Y., Su, Z., Xiang, Q., Zeng, R., & Zhang, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010394 · Cited by 2
Progression in the In Vitro Macrophage Expansion
Wei, Y., Yang, J., Zu, W., Wang, M., & Zhao, Y. X. (2025) · Journal of Immunology Research · doi:10.1155/jimr/9994439 · Cited by 2
Tang, S., Cui, Y., Xiao, Y., Li, W., Zhou, Y., Li, C., Ma, B., Li, C., Li, B., Fu, G., et al. (2025) · Advanced Materials · doi:10.1002/adma.202511606 · Cited by 2
Self-citationChen, Q., Peng, Y., Zhong, Q., Zhang, Y., Hu, L., Zhang, G.-Y., Xu, Y., Dong, P., Shen, S. Q., Wang, J., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03840-x · Cited by 2
Wang, H., Hu, H., Li, Y., Hu, L., Gu, C., Zhu, Y. T., Huang, J., Li, N., Jiang, S., Zu, S., et al. (2025) · Advanced Science · doi:10.1002/advs.202513474 · Cited by 2
Shi, Y., Zhang, Z., Liu, J., Xu, X., Xiao, X., Zhang, T., Zhang, Y., Cui, H., Li, X., & Chen, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1727378 · Cited by 2
Cardoso, C., Carvalho, A. F. S., Lara, E. S., Carneiro, F. S., Zaidan, I., Grossi, L. C., Montuori‐Andrade, A. C. M., Souza, J. A. M., Félix, F. B., Monteiro, A. H. A., et al. (2026) · Blood · doi:10.1182/blood.2025028733 · Cited by 2
Lin, Q., Wu, F., Zhang, L., Zhang, Y., Sun, S., Wu, X., & Hx, Y. (2026) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2026013 · Cited by 2
Research progress on macrophage regulation of atherosclerosis
Song, J., Yan, R., Li, P., Guo, J., Zhai, G., & Li, J. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1682994 · Cited by 2
Li, Q., Kong, H., Li, Q., Chen, T., Chen, L., Wang, F., Zhang, X., Wu, Y., Zhu, Y., Geng, Z., et al. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116344 · Cited by 2
Macrophage Metabolic Reprogramming-Related Osteoimmunity in Osteoporosis
Zhou, K., Wang, Z., & Zhang, M. (2026) · Calcified Tissue International · doi:10.1007/s00223-026-01477-y · Cited by 4
Yang, L., Abuduyimiti, T., Xi, Y., Coppola, G., Liu, C., & Jiang, S. (2026) · iScience · doi:10.1016/j.isci.2026.115307 · Cited by 2
Self-citationZhang, Y.-Q., Nie, R., Feng, Z.-Y., Fan, M., Shen, Z., Zhang, X., Zhang, J.-Y., Jiang, Y., Zhang, Q.-Y., Huang, K., et al. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.03.039 · Cited by 2
Chen, L., Li, X., Sun, X., Wang, X., Wu, J., Su, E., Wang, S., Sun, H., Ma, L., & Zou, Y. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2026.101535 · Cited by 2
Self-citationZhang, L., Chen, Y., Xu, P., Zheng, T., Sheng, J., Wang, Z., Wang, S., Ding, Y., Lü, J., Liu, X., et al. (2026) · Circulation · doi:10.1161/circulationaha.125.078873 · Cited by 2
Balaban, R., Moskowitz, O., Levinson, M., Ofer, N., Raizman, A., Kitron, G. L., Aviv, E., Camargo, S., Goldman, L., Leemann, A., et al. (2026) · Science Immunology · doi:10.1126/sciimmunol.aed1544 · Cited by 4
Yao, J., Wu, Y., Wang, X., Zhang, J. K., Shao, Y., Chen, H., Zhang, H., Li, H., Pan, J., Zhao, Y., et al. (2026) · Science Advances · doi:10.1126/sciadv.adw6666 · Cited by 2
Self-citationKanuri, S. H. (2024) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-024-00853-5 · Cited by 2
Feng, Y., Wang, Q., He, B., & Hou, X. (2024) · Emergency and Critical Care Medicine · doi:10.1097/ec9.0000000000000129 · Cited by 2
Ma, L., Zhao, L., Zhang, Y., Ma, Y., Shang, Q., & Liu, X. (2025) · Discover Oncology · doi:10.1007/s12672-025-02901-9 · Cited by 2
Xu, Y., Wang, D., Zhou, S., Yu, D., Deng, A., Lu, X., Feng, Q., Gu, Z., & Guo, Y. (2025) · Nano Research · doi:10.26599/nr.2025.94907775 · Cited by 2
Inhibition of inner ear macrophage phagocytosis alleviates cisplatin-induced ototoxicity
Zhang, J., Zhang, W., Huang, X., Li, M., & Yang, H. (2025) · Communications Biology · doi:10.1038/s42003-025-08525-7 · Cited by 2
Su, Y., Mei, J., Ye, R., Pan, X., Bao, H., Zheng, S., Du, Z., Xia, S., Shen, J., Lv, L., et al. (2025) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2025.11.044 · Cited by 2
MerTK-dependent efferocytosis by monocytic-MDSCs mediates resolution of post-lung transplant injuryPreprint
Leroy, V., Kollareth, D. J. M., Tu, Z., Valisno, J. A. C., Woolet-Stockton, M., Saha, B. K., Emtiazjoo, A. M., Rackauskas, M., Moldawer, L. L., Efron, P. A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.18.576261 · Cited by 2
Gong, Y., Yan, S. R., Fang, N., Zhang, Y., Zhang, N., Li, L., Wang, Z., Wang, K., Hou, T., Ji, X., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4666347/v1 · Cited by 2
Self-citationKırtay, M., Ispirjan, M., Bonnard, B., Bruggner, A.-L., Boehringer, L., Miessler, M., Frey, N., Leeper, N. J., & Jarr, K.-U. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.24.720546 · Cited by 2
Chen, L., Chen, Y., Zhao, M., Yang, X., Sutte, K., Lu, M., Chen, J., Zheng, X., Yang, D., & Liu, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1814879 · Cited by 1
Atherosclerosis and inflammation: therapeutic targets and ways of correction
Клименко, А. А., Andriyashkina, D. Y., & Ogarkova, K. I. (2024) · The Clinician · doi:10.17650/1818-8338-2024-18-1-k696 · Cited by 1
Lee, Y. J., Eo, E.-Y., Joo, D. H., Yoon, S.-M., Kim, H.-J., Song, M. J., Kwon, B. S., Lim, S. Y., Lim, S. Y., Lee, Y.-J., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-14536-5 · Cited by 1
Li, M., Xiao, S., Qin, Q., Fu, K., Wang, L., Li, X., Shu, C., & Li, J. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152589 · Cited by 1
Jenkins, S. J., & Gregory, C. D. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-92785-0_6 · Cited by 1
Shi, Z., Lu, X., Fei, H., Liu, X., Xu, S., Lin, Y., Fang, L., Jiang, L., & Zhang, S. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04590-1 · Cited by 1
Hoque, M. M., Kong, M., Xinyi, Y., Xiangyu, Z., Yeh, S. T.-Y., Long, K., Lin, H., & Cheng, K. K. Y. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.102837 · Cited by 1
Exclusion of Notch from the contact site during efferocytosis restricts anticancer immunity
Li, Z., Xu, B., Sharma, P., Guy, C. S., Boada-Romero, E., Verbist, K., Guo, A., Mari, L., Poudel, S., Yang, M., et al. (2026) · Nature Immunology · doi:10.1038/s41590-026-02452-3 · Cited by 2
Efferocytosis: Gateway for tissue resolution
Cho, S., & Ju, H. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261431219 · Cited by 1
Distinct necrotic protein cleavages define terminal events in necrosis
Li, G., Qi, W., Zhang, M., Xu, G., Li, Y., Sun, Z., Gao, Z., Li, P. Q., Shan, B., & Yuan, J. (2026) · Vita · doi:10.15302/vita.2026.04.0023 · Cited by 1
Wang, Z., Xiao, R., Liu, M., Ceng, L., Lin, Z., Zheng, X., Shi, M., Ye, H., Wu, L., & 唐南洪 (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2026-014993 · Cited by 1
Chen, Q., Liu, C., Wang, Q., Zhang, X., Zheng, Y., Guo, M., & Wang, J. (2026) · Molecular Immunology · doi:10.1016/j.molimm.2026.04.006 · Cited by 1
Self-citationMilk Fat Globule‐ EGF Factor 8 ( MFG ‐ E8 ): A Prominent Modulator of Tissue Repair
Zhang, W., Zhang, Y., Wang, H., Guan, L., Sun, J., & Lu, J. (2026) · The FASEB Journal · doi:10.1096/fj.202504798r · Cited by 1
FoxO signaling in regulated cell death and its therapeutic implications in inflammation
Zhang, K., Mo, C., Wen, B., Ma, Z., & Ma, D. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116830 · Cited by 1
Efferocytosis: Signaling Pathways and New Therapeutic Strategies for Diseases
Wang, L., Ge, J., Wang, Z., Fang, Y., Jia, Y., Zhang, R., & Qin, Y. (2026) · MedComm · doi:10.1002/mco2.70764 · Cited by 1
Macrophage EHD1 Promotes Inflammation and Stabilizes Sortilin to Accelerate Atherosclerosis
Ma, F., Liu, Y., Xu, Y., Liu, W., Gupta, N., Zhu, Y., Xiao, L., Swee, S., Adam, I., Zheng, E., et al. (2026) · Circulation Research · doi:10.1161/circresaha.125.327751 · Cited by 1
Self-citationDuolikun, D., Zhang, L., Wang, T., Wu, X., Guo, X., Zeeshan, W. M., Liu, Z., Zhang, H., Zhao, J., & 郑龙坡 (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.05.037 · Cited by 3
Defective efferocytosis in diabetes: molecular mechanisms and emerging therapeutic strategies
Lei, Y., Tang, M., Deng, H., Li, Y., Wu, J., Luo, L., Mou, Y., 吴千石, Li, Q., Xu, Y., et al. (2026) · Inflammation Research · doi:10.1007/s00011-026-02302-w · Cited by 1
Zhang, L., 周玮琰, Wu, Y., & Wang, B. (2026) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-026-10112-2 · Cited by 1
Insights into programmed cell death from multiple imaging modalities
Li, S. N., Zhang, X., Li, D., Hou, Y., Qian, Y., Xu, J., Gu, Q., Yang, M., & Chu, M. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08568-2 · Cited by 1
Song, J., Zhu, Y., Zhang, Y., Song, B., Liu, L., Song, Y., Shi, Y., Jiao, Y., Dang, J., Yu, Z., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.179531 · Cited by 1
Yuan, P., Tian, S., Cui, C., Sun, C., Tang, C., Gao, D., Lu, L., Long, K., Xu, F., Shu, G., et al. (2026) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2026.100626 · Cited by 1
Ran, Y., Luo, Y., Chen, Y., & Rao, X. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.07.054 · Cited by 2
Yu, X.-X., Zhuang, Z.-Y., Ge, R.-Y., Lin, S., Ren, J.-Y., Zhou, Y.-W., Zhang, J.-L., Li, Z., Li, G., Ji, J., et al. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.08.001 · Cited by 1
Zhang, S., Zha, L., Liu, C., Wang, A., Guo, Y., & Qian, K. X. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48080832 · Cited by 1
Self-citationZhou, J., & Tang, C. (2024) · Current Vascular Pharmacology · doi:10.2174/0115701611258090231221082502 · Cited by 1
The role of C5aR1-mediated hepatic macrophage efferocytosis in NASH
Shen, X., Zheng, W., Du, X., Chen, Y., song, X., Yang, L., & Yuan, Q. X. (2024) · Scientific Reports · doi:10.1038/s41598-024-68207-y · Cited by 1
Li, J., Lin, Q., Ren, C., Li, X., Li, X., Li, H., & Li, S. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002362 · Cited by 1
Li, J.-X., Wen, J., Ou, S., Qu, Y., Xia, C.-L., Li, W., Yang, Y., Liu, J.-B., Yang, R.-S., Zeng, W., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.163509 · Cited by 1
Macrophage WDFY3, a protector against autoimmunityPreprint
Wu, X., Wang, Z., Croce, K. R., Li, F., Cui, J. G., D’Agati, V. D., Soni, R. K., Khalid, S., Saleheen, D., Tabas, I. A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.17.608411 · Cited by 1
Self-citationAli, Y., Galbraith, T., Abdelfattah, N., Žiemys, A., Wong, T. L., Hashimoto, C., Faisal, M., Xu, Q., Cook, H., Pandita, T. K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.26.661471 · Cited by 1
Stage-resolved Spatial Multi-omics Reveals Myeloid Niches in Human Atherosclerotic PlaquesPreprint
Hou, P., Cai, H., Liu, Z., Fang, J., Wang, Z., Wang, S., Lyu, Q., Li, P., Shao, C., Melino, G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.09.681522 · Cited by 1
Dying cell-derived SAM switches off inflammation
Maeyer, R. P. H. D., & Gilroy, D. W. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00556-2
shi, Y., Gong, P., Ding, Y., Li, W., Su, X., Tian, R., Zhou, Y., Wang, T., Jiang, J., Liu, R., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1819715/v1
Cui, K., Gao, X., Wang, B., Wu, H., Dong, Y., Xiao, Y., Jiang, X., Malovichko, M. V., Li, K. S., Peng, Q., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.09.503334
Self-citationZhang, S., Zhao, X., Liu, L., Fang, J., Liu, W., & Zhang, H. (2023) · Research Square · doi:10.21203/rs.3.rs-2661427/v1
The effect of hyperglycemia on the activation of peritoneal macrophages of albino rats
Голяко, И. А., Kuzmin, V. S., & Горбачева, Л. Р. (2023) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20236906394
Avaliação da morte de linfócitos induzida pela saliva de Aedes aegypti
de Assis, J. B. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2023.tde-24012024-160811
Shen, Y., Liu, X., Li, C., Fan, Y., Zhou, Z.-Y., Xiu, W., Tang, B., Wang, L., Song, H., Tang, J., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4420177/v1
Transcriptional analysis of efferocytosis in mouse skin woundsPreprint
Krause, W., King, D. E., & Horsley, V. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.12.607219 · Cited by 1
The role of macrophages in atherosclerosis
Qin, M. (2024) · New cell · doi:10.61958/ncfu8221
Adrenergic Regulation of Cardiac Macrophages: Heterogeneity, Plasticity, and Therapeutic Potential
Xiang, W., Wang, M., Yu, H., Lu, H., & Wang, Y. (2024) · International Journal of Drug Discovery and Pharmacology · doi:10.53941/ijddp.2024.100020
Adjuvant therapy of osteoarthritis with bioregulatory drugs
Zotkin, E. G., & Shkireeva, S. Y. (2025) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2025-1-98-104
Adé, K., Zhao, K., & Bowdish, D. M. E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00171-x
Roy, A., Bzdak, V. A., Sinha, M., Komar, A. A., Jiang, P., & Mazumder, B. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf102
Metadata
- Authors
- Gerlach, B. D., Ampomah, P. B., Yurdagul, A., Liu, C., Lauring, M. C., Wang, X., Kasikara, C., Kong, N., Shi, J., Tao, W., & Tabas, I.
- Affiliations
- Columbia University Irving Medical Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Tabas, Ira
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2021-12
- Volume
- 33
- Issue
- 12
- Pages
- 2445-2463.e8
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC8665147
- OpenAlex
- W3212263362
- Cited by
- 360
- References
- 71
- Citations by year
- 2026: 79 · 2025: 105 · 2024: 91 · 2023: 53 · 2022: 31 · 2021: 1
- FWCI
- 16.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 371 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (R35 HL145228, K99 HL145131, P20 GM121307, P30CA013696, R01 HL087123, R01 HL127464, S10OD020056, S10RR025686, S10RR027050, T32 5T32HL007343-42)
- American Heart Association (20POST35210962)
- Harvard Medical School (122829)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- efferocytosis, macrophage proliferation, DNA-PKcs, mTORC2, Rictor, c-Myc, atherosclerosis regression, plaque stabilization, peritonitis, thymocyte apoptosis, phagolysosomes
- MeSH terms
- Animals, Macrophages, Mice, Inbred C57BL, Phagocytosis, Apoptosis, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review